Population Screening Market Size Worth $43.91 Billion By 2032 | CAGR: 5.6%

The global population screening market size is expected to reach USD 43.91 billion by 2032, according to a new study by Polaris Market Research. The report “Population Screening Market Share, Size, Trends, Industry Analysis Report, By Geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness about disease detection and treatment will be a significant factor influencing the growth of the health screening market. In addition, increasing urbanization and disposable income are driving factors accelerating the development of the health screening market. Furthermore, rising healthcare infrastructure spending and people's ever-changing lifestyles are major market drivers that will propel the health screening market forward.

Increasing emphasis on preventive healthcare, the launch of technologically advanced products, growing research and development activities, rising per capita income leading to improving the standard of living, and increasing awareness about the advantages of a healthy lifestyle are expected to propel the market growth during the forecast period. Thus, the government takes the initiative, which drives the market. For instance, The Maharashtra state government announced a health check-up campaign in October 2022 as a preventive measure for women's safety in the state. Various health-related tests will be performed as part of this campaign to complete 30 million women's health tests.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/population-screening-market/request-for-sample

The growing volume and availability of healthcare data and the increasing need to provide quality care to patients will force healthcare organizations to rely on these new methodologies. This will be used as a strategic competency to distinguish themselves from competitors and capitalize on growth opportunities.

The nation's population screening market is anticipated to benefit from the COVID-19 pandemic. For instance, Hayatt Med-Tech startup created the fully automated Hayatt Thermox-D in June 2021 to perform quick COVID-19 testing. With self-disinfection after each session, this device can screen multiple parameters and detect acute symptoms in 12 seconds. Thus, introducing new analytical technologies is expected to boost market expansion.

Population Screening Market Report Highlights

• Nation segment is anticipated to grow over the forecast period because of the effectiveness and precision offered by CTCs in cancer detection
• The hardware equipment segment held a dominant share of the market in 2022 Because of the acceptance of new test kits and tools for expanding population screening of more diseases
• The hospital segment will generate the most revenue in 2022 owing to the rising prevalence of chronic diseases, the availability of multiple testing options, and the introduction of new tests for better and more effective patient screening.
• North America will dominate the population screening market in 2022, owing to preventive measures implemented by governments to halt disease progression.
• The global players include Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Roche Ltd., Quest Diagnostics, and Illumina

Polaris Market Research has segmented the population screening market report based on geography, product, application, and region:

Population screening, Geography Outlook (Revenue - USD Billion, 2019 - 2032)

• Nation
• State

Population screening, Product Outlook (Revenue - USD Billion, 2019 - 2032)

• Hardware Equipment
• Testing / Lab
• Analytics / Interpretation

Population screening, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Hospitals
• Research Institutes
• Diagnostic Labs

    Population screening, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa